Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

TELA Bio (TELA) Operating Margin (2018 - 2025)

TELA Bio (TELA) has 8 years of Operating Margin data on record, last reported at 36.51% in Q3 2025.

  • For Q3 2025, Operating Margin rose 1289.0% year-over-year to 36.51%; the TTM value through Sep 2025 reached 46.02%, up 939.0%, while the annual FY2024 figure was 49.23%, 2617.0% up from the prior year.
  • Operating Margin reached 36.51% in Q3 2025 per TELA's latest filing, up from 44.96% in the prior quarter.
  • Across five years, Operating Margin topped out at 29.07% in Q1 2024 and bottomed at 123.69% in Q1 2021.
  • Average Operating Margin over 5 years is 75.36%, with a median of 72.23% recorded in 2023.
  • Peak YoY movement for Operating Margin: surged 6543bps in 2024, then plummeted -2748bps in 2025.
  • A 5-year view of Operating Margin shows it stood at 91.4% in 2021, then rose by 11bps to 81.22% in 2022, then increased by 11bps to 72.23% in 2023, then surged by 34bps to 47.33% in 2024, then grew by 23bps to 36.51% in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Margin were 36.51% in Q3 2025, 44.96% in Q2 2025, and 56.54% in Q1 2025.